Skip to Main Content

Author Details

Ian Solsky
Wake Forest University
2015
39
8
PMIDPaper TitleJournal TitlePublished Year
37980711Distance Traveled and Disparities in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Ann Surg Oncol2024
37654225The Impact of Frailty on Adjuvant Therapies Not Offered to or Declined by Breast Cancer Surgery Patients.Am Surg2024
37891454Quality-of-Life Outcomes for Patients Taking Opioids and Psychotropic Medications Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Ann Surg Oncol2024
36285743Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).J Surg Oncol2023
37020096ASO Visual Abstract: Survival Outcomes of Optimally Treated Colorectal Metastases-The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease.Ann Surg Oncol2023
37341164Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patients.J Surg Oncol2023
37198337Potentially Avoidable Admissions and Prolonged Hospitalization in Patients with Suspected Colon Cancer.Ann Surg Oncol2023
36859704Conditional Survival After Hepatectomy for Colorectal Liver Metastasis: Results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).Ann Surg Oncol2023
36914908ASO Visual Abstract: Conditional Survival After Hepatectomy for Colorectal Liver Metastasis-Results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).Ann Surg Oncol2023
36681734ASO Visual Abstract: Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy; Does It Affect Intraperitoneal Hyperthermic Chemotherapy Perfusion?Ann Surg Oncol2023
36484904Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?Ann Surg Oncol2023
36823339ASO Visual Abstract: Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.Ann Surg Oncol2023
36754945Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.Ann Surg Oncol2023
36754944Survival Outcomes of Optimally Treated Colorectal Metastases: The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease.Ann Surg Oncol2023
35969300Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?Ann Surg Oncol2023
32941270Smartphone-based Assessment of Preoperative Decision Conflict and Postoperative Physical Activity Among Patients Undergoing Cancer Surgery: A Prospective Cohort Study.Ann Surg2022
34283380Feasibility and performance of smartphone-based daily micro-surveys among patients recovering from cancer surgery.Qual Life Res2022
32812109Smartphone Global Positioning System (GPS) Data Enhances Recovery Assessment After Breast Cancer Surgery.Ann Surg Oncol2021
33731272Corrigendum to "Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations" [Gynecologic Oncology 156 (2020) 363-376].Gynecol Oncol2021
34179891Expected Versus Experienced Health-Related Quality of Life Among Patients Recovering From Cancer Surgery: A Prospective Cohort Study.Ann Surg Open2021
34053640Surgical Treatment for Gastric Cancer.Gastrointest Endosc Clin N Am2021
30528925World Health Organization Surgical Safety Checklist Modification: Do Changes Emphasize Communication and Teamwork?J Surg Res2020
31918993Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations.Gynecol Oncol2020
31657854Using Smartphones to Capture Novel Recovery Metrics After Cancer Surgery.JAMA Surg2020
33425440Providing Reliable Prognosis to Patients with Gastric Cancer in the Era of Neoadjuvant Therapies: Comparison of AJCC Staging Schemata.J Gastric Cancer2020
32851517ASO Author Reflections: Applications of Smartphone-Based Digital Phenotyping in Supplementing Recovery Assessment After Cancer Surgery.Ann Surg Oncol2020
32409594Utilizing Cultural and Ethnic Variables in Screening Models to Identify Individuals at High Risk for Gastric Cancer: A Pilot Study.Cancer Prev Res (Phila)2020
32563008Diagnosis Setting and Colorectal Cancer Outcomes: The Impact of Cancer Diagnosis in the Emergency Department.J Surg Res2020
30691842Lack of Cancer Recurrence Data in Large Databases: A National Survey of Hospital Cancer Registries.J Surg Res2019
30109389Ten Years and Counting: Sustaining Effectiveness of the Surgical Safety Checklist Through Ongoing Implementation Efforts.World J Surg2019
31353063Redefining shared decision-making in the digital era.Eur J Surg Oncol2019
31121583Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.Respiration2019
29108643Gastric cancer diagnosis after presentation to the ED: The independent association of presenting location and outcomes.Am J Surg2018
29718354Effectiveness of a WHO Safe Childbirth Checklist Coaching-based intervention on the availability of Essential Birth Supplies in Uttar Pradesh, India.Int J Qual Health Care2018
27909825Poor Outcomes of Gastric Cancer Surgery After Admission Through the Emergency Department.Ann Surg Oncol2017
28895113Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database.Ann Surg Oncol2017
27305884Draining T-Tube Jejunostomy: A Technique to Get Out of Trouble.Am Surg2016
27622571Perioperative care map improves compliance with best practices for the morbidly obese.Surgery2016
26061660Diarrhea, Weight Loss, and an Ampullary Mass. Intraductal papillary mucinous neoplasm.JAMA Surg2015
  • 1 - 39 of 39

Recommended Authors

Princess Margaret Hospital
Career Start Year 2017
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 0
Imperial College London
Career Start Year 2016
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2015
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2015
Number of shared co-authors 0
Lahey Hospital and Medical Center
Career Start Year 2014
Number of shared co-authors 0
Harvard T.H. Chan School of Public Health
Career Start Year 2013
Number of shared co-authors 0
Center for Surgery and Public Health, Brigham and Women's Hospital
Career Start Year 2013
Number of shared co-authors 6
Vanderbilt University Medical Center
Career Start Year 2011
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus.
Career Start Year 2011
Number of shared co-authors 0
Singapore General Hospital
Career Start Year 2010
Number of shared co-authors 0
University of Oxford
Career Start Year 2008
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2008
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 3
University of California
Career Start Year 2007
Number of shared co-authors 0
University of Texas Southwestern Medical Center
Career Start Year 2006
Number of shared co-authors 0
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
Department of Health Services Research, Mayo Clinic
Career Start Year 2005
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 0
University of California San Diego
Career Start Year 2004
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 0
University of California
Career Start Year 2002
Number of shared co-authors 0
Harborview Medical Center
Career Start Year 2002
Number of shared co-authors 0
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Memorial-Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Odette Cancer Centre
Career Start Year 1996
Number of shared co-authors 1
Surgical Outcomes Research Center, University of Virginia
Career Start Year 1996
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus.
Career Start Year 1992
Number of shared co-authors 0

Collaborators

Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health
Co-authored papers 9
Harvard Medical School
Co-authored papers 4
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 2
Brigham and Women's Hospital and the Harvard T.H. Chan School of Public Health
Co-authored papers 2
Co-authored papers 1
Jacobi Medical Center
Co-authored papers 1
Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
Montefiore Medical Center/Albert Einstein College of Medicine
Co-authored papers 1
Co-authored papers 1
Stanford University School of Medicine.
Co-authored papers 1
Midas Multi-Specialty Hospital
Co-authored papers 1
University of California - Los Angeles
Co-authored papers 1
Duke Cancer Center Cary
Co-authored papers 1